We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.
- Authors
Juwan Park; Hyun Kyung Cho; Jung-Il Moon
- Abstract
Purpose: To confirm the possible mechanism by which topical prostaglandin antiglaucoma drugs cause a deep superior sulcus. Methods: Among patients who used bimatoprost (Lumigan), latanoprost (Xalatan), or travoprost (Travatan) and who developed a deep upper lid sulcus, 18 eyes of 11 patients (mean age, 58.2 ± 8.9 years) were studied. Seven patients were binocular users of one of the eye drops and four were monocular users. Preaponeurotic orbital fat was obtained, and the mean adipocyte density compared. Results: In the four monocular users, mean adipocyte density of treated eyes was 1758.21 ± 158.15 cells/mm, and that of untreated eyes was 1258.73 ± 127.54 cells/mm. This difference was statistically significant ( P = 0.04), suggesting that the adipocytes were atrophied in the treated eyes. The mean adipocyte density of the bimatoprost group was 2073.35 ± 184.89 cells/mm, that of the travoprost group was 1623.46 ± 218.99 cells/mm, and that of the latanoprost group was 1468.20 ± 113.44 cells/mm. The densities of the bimatoprost and travoprost groups, but not of the latanoprost group ( P = 0.75), were significantly different from that of the untreated group ( P < 0.001). Conclusions: Fat atrophy can be considered a mechanism of upper eyelid sulcus deepening in patients using topical prostaglandin analogs.
- Subjects
PROSTAGLANDINS; GLAUCOMA; EYE diseases; OPHTHALMOLOGY; ATROPHY
- Publication
Japanese Journal of Ophthalmology, 2011, Vol 55, Issue 1, p22
- ISSN
0021-5155
- Publication type
Article
- DOI
10.1007/s10384-010-0904-z